Enochian BioSciences (NASDAQ: ENOB)
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-09-23 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.120 | ||||||
REV | 0 |
You can purchase shares of Enochian BioSciences (NASDAQ: ENOB) through any online brokerage.
Other companies in Enochian BioSciences’s space includes: Anixa Biosciences (NASDAQ:ANIX), OncoCyte (NASDAQ:OCX), Ambrx Biopharma (NYSE:AMAM), TCR2 Therapeutics (NASDAQ:TCRR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
There is no analysis for Enochian BioSciences
The stock price for Enochian BioSciences (NASDAQ: ENOB) is $1.93 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Enochian BioSciences.
Enochian BioSciences’s Q4 earnings are confirmed for Friday, September 23, 2022.
There is no upcoming split for Enochian BioSciences.
Enochian BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.